NCT02071888 2018-07-18Study of the Glutaminase Inhibitor CB-839 in Hematological TumorsCalithera Biosciences, IncPhase 1 Completed25 enrolled
NCT00150462 2017-05-02Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesAmgenPhase 1 Completed48 enrolled 26 charts